InsidersTradesSigma
Apyx Medical Corp Stock: price and directors' dealings · United States · SEC (Form 4)
Follow the Apyx Medical Corp share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Operating in the Health Care sector, Apyx Medical Corp has logged 22 insider filings. Market capitalisation: €181.1m. The latest transaction was disclosed on 2 July 2026 (Levée d'options). Among the most active insiders: Waldman Lawrence. The full history is accessible without an account.
22
Insider Decl.
0
Thresholds
€101,929
5 ops.
Buy Volume
·
0 ops.
Sell Volume
46Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 22,087 of 25,596 companies
25.6
score / 100
Value21
Quality31
FCF yld-5.0%
Earn yld-6.2%
EV/EBITDA·
ROE-76%
Gross mgn63%
Net mgn-21%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 2 July 2026
Declarations22 total
12,000 sharesCommon StockSEC:0001493152-26-031944:0
5,024 sharesCommon StockSEC:0001493152-26-031944:1
15,000 sharesCommon StockSEC:0001493152-26-029122:0
10,533 sharesCommon StockSEC:0001493152-26-029122:1
450,000 sharesRestricted Stock UnitsSEC:0001493152-26-028771:0
6,000 shares@ US$1.1336.8% of flowCommon StockSEC:0001493152-25-008863:0
Ideal exit: 10 May 2025 (T+270)
5,336 shares@ US$1.1332.8% of flowCommon StockSEC:0001493152-24-031725:0
Ideal exit: 10 May 2025 (T+270)
2,500 shares@ US$2.1930.4% of flowCommon StockSEC:0001493152-23-044805:0
Ideal exit: 7 Sept 2024 (T+270)
50,000 shares@ US$1.5786.1% of flowCommon StockSEC:0001493152-23-041501:0
Ideal exit: 10 Aug 2024 (T+270)
5,338 shares@ US$2.9714.8% of flowCommon StockSEC:0001493152-23-024899:0
15,000 shares@ US$1.7750.0% of flowCommon StockSEC:0000719135-23-000040:0
15,000 shares@ US$1.7750.0% of flowCommon StockSEC:0000719135-23-000036:0
10,000 shares@ US$2.7950.2% of flowCommon StockSEC:0000719135-23-000030:0
7,173 shares@ US$9.4243.8% of flowCommon StockSEC:0000719135-23-000020:0
2,000 shares@ US$5.9313.9% of flowCommon StockSEC:0000719135-22-000084:0
Ideal exit: 26 May 2023 (T+270)
30,000 shares@ US$2.54100.0% of flowCommon StockSEC:0000719135-22-000055:0
4,000 shares@ US$2.5419.2% of flowCommon StockSEC:0000719135-22-000050:0
30,000 shares@ US$2.54100.0% of flowCommon StockSEC:0000719135-22-000052:0
24,000 shares@ US$2.5463.2% of flowCommon StockSEC:0000719135-22-000053:0
8,000 shares@ US$2.790.013% mcap100.0% of flowCommon StockSEC:0000719135-22-000037:0
6,000 shares@ US$2.790.0096% mcap100.0% of flowCommon StockSEC:0000719135-22-000035:0
17,000 shares@ US$4.980.046% mcap100.0% of flowCommon StockSEC:0000719135-22-000024:0
22 of 22 declarations
About Apyx Medical Corp
Apyx Medical Corp is a company focused on developing medical technologies, including surgical and skin care devices. It emphasizes innovation in the healthcare and pharmaceutical sectors.